MiraDx is a biotechnology company based in Los Angeles, California, specializing in innovative diagnostic solutions. Situated at 11601 Wilshire Blvd Suite 105 Plaza Level, the company focuses on advancing molecular diagnostics through cutting-edge technology and research. MiraDx’s operations are centered on developing tools that enable more precise and timely detection of various medical conditions, contributing to the broader field of personalized medicine.
The company’s expertise lies in integrating molecular biology techniques with modern data analysis to improve the accuracy and efficiency of diagnostic testing. By leveraging advancements in genomics and bioinformatics, MiraDx aims to support healthcare providers with actionable insights that can enhance patient outcomes. Its Los Angeles location positions the company within a vibrant biotech community, fostering collaboration and innovation in the life sciences sector.
MiraDx is equipped to handle complex diagnostic challenges, offering solutions that span multiple areas of healthcare. The company’s focus on research-driven development ensures that its products remain aligned with emerging scientific trends and clinical needs. This approach reflects a commitment to addressing the evolving demands of diagnostics, making MiraDx a notable presence in California’s biotechnology landscape.
Through continuous innovation and a scientific approach to problem-solving, MiraDx contributes to the advancement of diagnostic methodologies. Its work supports the broader goal of improving healthcare delivery by providing tools that enhance disease detection and management. As a biotechnology company in Los Angeles, MiraDx plays a role in shaping the future of medical diagnostics within the region and beyond.


































